HIV Lipodystrophy

This is a condition that affects people with HIV. It causes their body to lose fat in some areas, like the face and neck, and gain fat in other areas, like the abdomen. It's thought to be caused by a mix of factors related to the HIV infection itself, the medicines used to treat it, and other things.

Condition

What people with HIV Lipodystrophy report

Every report comes from a Lived member, sent anonymously.

Have you had Dermal fillers for HIV Lipodystrophy?

NameHow it went

About HIV Lipodystrophy

What It Is

HIV lipodystrophy is a change in how the body stores fat in some people living with HIV. Fat may be lost from under the skin of the face, arms, legs and buttocks, a pattern called lipoatrophy. Fat may also build up deep in the belly around the organs, on the back of the neck between the shoulders (sometimes called a buffalo hump) or in the breasts, a pattern called lipohypertrophy. Some people have one pattern, and some have both. The changes matter for two reasons. They can alter how a person looks, especially when the cheeks become hollow, which many people find distressing and which can feel like a visible sign of HIV. They also tend to come with metabolic problems, including insulin resistance (the body responding poorly to insulin), type 2 diabetes, high cholesterol and triglycerides, and fat in the liver, which together raise the risk of heart disease over time.

Causes & Risk Factors

The clearest cause of fat loss is a group of older HIV medicines, especially stavudine and zidovudine, which belong to a class called nucleoside reverse transcriptase inhibitors (NRTIs). Lipodystrophy was first recognized in the years after combination HIV treatment arrived in the mid-1990s, when these drugs were widely used. As HIV treatment moved to newer, less toxic medicines, new cases of obvious lipodystrophy became much less common. Some protease inhibitors, another class of HIV medicine, have also been linked to fat changes. Belly fat gain is harder to pin on one drug. Research suggests it is largely related to treating HIV itself rather than to one particular medicine, and it does not reliably improve after switching drugs. Other factors linked to a higher risk include being older, being female, having a family tendency and being under or over a healthy weight. Today the condition is seen mostly in people who took older medicines for many years, including those who started treatment as children. Modern regimens can still cause general weight gain that looks like ordinary obesity, which is related but is not the classic pattern.

How It's Diagnosed

There is no single test and no agreed standard for diagnosing HIV lipodystrophy. A clinician usually recognizes it from the person's history (which HIV medicines they have taken and for how long), the changes the person or their family has noticed, and a physical examination of the face, limbs, belly and neck. Body measurements such as waist size, repeated over time, can help track whether changes are progressing. Because the metabolic side of the condition is often silent, blood tests are an important part of the assessment. These typically check cholesterol and triglycerides, blood sugar and liver tests. The clinician will also consider other explanations for changes in weight or shape,, such as general weight gain or other illnesses.

Treatment Options

Treatment depends on which changes a person has and how much they affect health and well-being. Effective HIV treatment remains the foundation, so stopping HIV medicines is not a way to reverse the changes. If someone is still taking an older medicine linked to fat loss, switching to a newer regimen can stop further loss and may let some fat slowly return. Recovery is often partial, and many people who developed fat loss years ago do not fully regain it. Regular exercise and a healthy diet can reduce belly fat and improve blood sugar and cholesterol, and they are a sensible first step. Treating the metabolic problems directly also matters: managing high cholesterol and diabetes with the usual medicines helps limit long-term complications, even when body shape changes little. Tesamorelin (Egrifta SV or Egrifta WR) is a daily injection approved for adults with HIV lipodystrophy to reduce excess fat deep in the belly. It works by prompting the body to release more of its own growth hormone. In studies it reduced this fat noticeably over six months without changing overall weight, but the fat tended to return after the injections stopped. It can raise blood sugar, so glucose is checked before and during treatment, and it is not used in pregnancy. For facial fat loss, injectable dermal fillers are FDA-approved to restore volume to the cheeks and face in people with HIV. Liposuction is sometimes used to remove a prominent fat pad at the back of the neck, although the fat returns in some people.

What to Expect

Fat changes usually develop gradually and, once established, tend to be long-lasting. People who switched off older medicines often find that the changes stop progressing, but improvement in lost facial or limb fat is slow and frequently incomplete. Belly fat gain can respond to exercise, diet and specific treatment, though it may return when treatment stops. The emotional side can be as significant as the physical one. Some people avoid social situations or feel tempted to skip HIV medicines because of how they look, and that can put their HIV control at risk. Talking openly with the care team, and with counselors or peer support groups where available, can help. Ongoing care usually includes regular checks of cholesterol, blood sugar and blood pressure, since managing these is what protects long-term heart and metabolic health.

When to Seek Help

Mention any change in body shape, such as thinning cheeks, thinner arms or legs, a growing belly or fat at the back of the neck, at your next HIV care visit, so it can be measured and its cause considered. Contact your care team before making any change to your HIV medicines, and do not stop them on your own because of body changes. Arrange a prompt visit if you develop signs of high blood sugar, such as unusual thirst, frequent urination or unexplained tiredness, or if a treatment for fat changes causes troubling swelling or joint pain.

Questions to Ask Your Doctor

  1. 1.Are the changes in my body likely to be related to my current or past HIV medicines?
  2. 2.Would switching my HIV regimen help, and what could I realistically expect to change?
  3. 3.Which blood tests should I have to check my cholesterol, blood sugar and liver, and how often?
  4. 4.Am I a candidate for treatments such as tesamorelin, facial fillers or surgery, and what are the trade-offs?
  5. 5.What support is available if these changes are affecting how I feel about myself or my treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.